All In Biotech

Free tool

FAERS Monitor: Nicotrol

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 020385 or its brand name (Nicotrol, Nicotine). Reports on generic versions are filed under their own applications.

Reports

17,295

Serious

11,425

66% of reports

Hospitalization

4,810

Death reported

1,618

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • drug ineffective2,091
  • nausea1,137
  • headache789
  • overdose780
  • foetal exposure during pregnancy755
  • nicotine dependence741
  • product adhesion issue734
  • dyspnoea683
  • treatment noncompliance672
  • malaise671
  • pain632
  • dizziness629
  • toxicity to various agents607
  • anxiety598
  • off label use579

Reports by year received

View as table
YearReports
2004240
2005233
2006331
2007445
2008329
2009455
2010758
2011701
2012792
2013491
2014625
2015713
2016854
2017750
20182,020
20191,265
20201,203
2021934
2022909
2023896
2024902
2025847
2026602

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,036,864 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
nicotine dependenceSignal741127.9118.884,360
product adhesion issueSignal73425.523.716,917
treatment noncomplianceSignal67215.114.08,755
foetal exposure during pregnancySignal75511.410.67,108
overdoseSignal7804.44.12,067
toxicity to various agentsSignal6074.44.11,592
anxietySignal5982.62.4573
drug ineffective2,0911.91.9999
malaise6711.91.7272
nausea1,1371.71.7377
dizziness6291.51.4119
headache7891.51.4149
dyspnoea6831.51.4104
pain6321.31.233
off label use5790.80.729

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.